Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Jan;55(1):138–148. doi: 10.1172/JCI107904

Inhibition of hormone-stimulated lipolysis by clofibrate. A possible mechanism for its hypolipidemic action.

M A D'Costa, A Angel
PMCID: PMC301725  PMID: 162783

Abstract

The present study was undertaken to investigate the mechanism of the antilipolytic action of clofibrate (p-chlorophenoxyisobutyrate). Clofibrate, in the dose range of 10-80 mg/199 ml, inhibited the initial rate of norepinephrine-stimulated lipolysis 17-44 percent in isolated rat fat cells. At a dose corresponding to therapeutic levels in vivo (10 mg/100 ml) clofibrate also inhibited hormone-stimulated lipolysis by 20-30 percent in fragments of human subcutaneous fat. Inhibition of lipolysis by clofibrate occurred at all concentrations of norepinephrine and ACTH (0.02-0.1 mug/ml) but did not occur with equilipolytic concentrations of dibutyryl cyclic AMP, suggesting a proximal site of action on the lipolytic sequence. Clofibrate reduced by 60 percent (315plus or minus40 vs. 120plus or minus25 pmol/g lipid; meanplus or minusSEM) the norepinephrine-stimulated initial rise in cyclic AMP, measured 10 min after addition of hormone. Because the antilipolytic effect occurred in the presence of glucose and without altering cellular ATP levels, the reduction in intracellular cyclic AMP levels could not be attributed to uncoupling of oxidative metabolism or to secondary effects of free fatty acid accumulation. In the secondary effects of free fatty acid accumulation. In the presence of procaine-HC1, which blocks hormone-stimulated lipolysis without inhibiting cyclic AMP accumulation, addition of clofibrate prevented the hormone-stimulated rise in cyclic AMP. Clofibrate did not affect the activity of the low-Km 3',5'-cyclic AMP phosphodiesterase in norepinephrine-stimulated adipocytes. These data suggest that the antilipolytic effect of clofibrate is due to its suppression of cyclic AMP production by inhibition of adenylate cyclase. The drug's hypolipidemic action may in part be explained by its antilipolytic effect, which deprives the liver of free fatty acid substrate for lipoprotein synthesis.

Full text

PDF
138

Images in this article

145Image
on p.145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AVOY D. R., SWYRYD E. A., GOULD R. G. EFFECTS OF ALPHA-P-CHLOROPHENOXYISOBUTYRYL ETHYL ESTER (CPIB) WITH AND WITHOUT ANDROSTERONE ON CHOLESTEROL BIOSYNTHESIS IN RAT LIVER. J Lipid Res. 1965 Jul;6:369–376. [PubMed] [Google Scholar]
  2. AZARNOFF D. L., TUCKER D. R., BARR G. A. STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE). Metabolism. 1965 Sep;14:959–965. doi: 10.1016/0026-0495(65)90111-3. [DOI] [PubMed] [Google Scholar]
  3. Adams L. L., Webb W. W., Fallon H. J. Inhibition of hepatic triglyceride formation by clofibrate. J Clin Invest. 1971 Nov;50(11):2339–2346. doi: 10.1172/JCI106732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Angel A., Desai K. S., Halperin M. L. Reduction in adipocyte ATP by lipolytic agents: relation to intracellular free fatty acid accumulation. J Lipid Res. 1971 Mar;12(2):203–213. [PubMed] [Google Scholar]
  5. Angel A. Studies on the compartmentation of lipid in adipose cells. I. Subcellular distribution, composition, and transport of newly synthesized lipid: liposomes. J Lipid Res. 1970 Sep;11(5):420–432. [PubMed] [Google Scholar]
  6. BEST M. M., DUNCAN C. H. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT. J Lab Clin Med. 1964 Oct;64:634–642. [PubMed] [Google Scholar]
  7. Barrett A. M. The effect of chlorophenoxyisobutyric acid on the release of free fatty acids from isolated adipose tissue in vitro. Br J Pharmacol Chemother. 1966 Feb;26(2):363–371. doi: 10.1111/j.1476-5381.1966.tb01916.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Barrett A. M., Thorp J. M. Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs. Br J Pharmacol Chemother. 1968 Feb;32(2):381–391. doi: 10.1111/j.1476-5381.1968.tb00980.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Barter P. J., Nestel P. J., Carroll K. F. Precursors of plasma triglyceride fatty acid in humans. Effects of glucose consumption, clofibrate administration, and alcoholic fatty liver. Metabolism. 1972 Feb;21(2):117–124. doi: 10.1016/0026-0495(72)90063-7. [DOI] [PubMed] [Google Scholar]
  10. Bierman E. L., Brunzell J. D., Bagdade J. D., Lerner R. L., Hazzard W. R., Porte D., Jr On the mechanism of action of atromid-S on triglyceride transport in man. Trans Assoc Am Physicians. 1970;83:211–224. [PubMed] [Google Scholar]
  11. Bihler I., Jeanrenaud B. ATP content of isolated fat cells. Effects of insulin, ouabain, and lipolytic agents. Biochim Biophys Acta. 1970 May 5;202(3):496–506. doi: 10.1016/0005-2760(70)90120-7. [DOI] [PubMed] [Google Scholar]
  12. Birnbaumer L., Rodbell M. Adenyl cyclase in fat cells. II. Hormone receptors. J Biol Chem. 1969 Jul 10;244(13):3477–3482. [PubMed] [Google Scholar]
  13. Boberg J., Carlson L. A., Fröberg S. O., Orö L. Effect of a hypolipidaemic drug (CH 13,437) on plasma and tissue lipids, and on the intravenous fat tolerance in man. Atherosclerosis. 1970 Mar-Apr;11(2):353–360. doi: 10.1016/0021-9150(70)90074-2. [DOI] [PubMed] [Google Scholar]
  14. Butcher R. W., Baird C. E., Sutherland E. W. Effects of lipolytic and antilipolytic substances on adenosine 3',5'-monophosphate levels in isolated fat cells. J Biol Chem. 1968 Apr 25;243(8):1705–1712. [PubMed] [Google Scholar]
  15. Carlson L. A., Walldius G., Butcher R. W. Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat. Atherosclerosis. 1972 Nov-Dec;16(3):349–357. doi: 10.1016/0021-9150(72)90082-2. [DOI] [PubMed] [Google Scholar]
  16. Cenedella R. J., Jarrell J. J., Saxe L. H. Effects of ethyl-p-chlorophenoxyisobutyrate, clofibrate, on the plasma and red blood cell free fatty acids of the rat. J Atheroscler Res. 1968 Nov-Dec;8(6):903–911. doi: 10.1016/s0368-1319(68)80004-3. [DOI] [PubMed] [Google Scholar]
  17. Corbin J. D., Krebs E. G. A cyclic AMP--stimulated protein kinase in adipose tissue. Biochem Biophys Res Commun. 1969 Jul 23;36(2):328–336. doi: 10.1016/0006-291x(69)90334-9. [DOI] [PubMed] [Google Scholar]
  18. Corbin J. D., Reimann E. M., Walsh D. A., Krebs E. G. Activation of adipose tissue lipase by skeletal muscle cyclic adenosine 3',5'- monophosphate-stimulated protein kinase. J Biol Chem. 1970 Sep 25;245(18):4849–4851. [PubMed] [Google Scholar]
  19. Denton R. M., Yorke R. E., Randle P. J. Measurement of concentrations of metabolites in adipose tissue and effects of insulin, alloxan-diabetes and adrenaline. Biochem J. 1966 Aug;100(2):407–419. doi: 10.1042/bj1000407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Desai K. S., Li K. C., Angel A. Bimodal effect of insulin on hormone-stimulated lipolysis: relation to intracellular 3',5'-cyclic adenylic acid and free fatty acid levels. J Lipid Res. 1973 Nov;14(6):647–655. [PubMed] [Google Scholar]
  21. GARLAND P. B., RANDLE P. J. A rapid enzymatic assay for glycerol. Nature. 1962 Dec 8;196:987–988. doi: 10.1038/196987a0. [DOI] [PubMed] [Google Scholar]
  22. Gilman A. G. A protein binding assay for adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A. 1970 Sep;67(1):305–312. doi: 10.1073/pnas.67.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Greene H. L., Herman R. H., Zakim D. The effect of clofibrate on rat tissue adenyl cyclase. Proc Soc Exp Biol Med. 1970 Sep;134(4):1035–1038. doi: 10.3181/00379727-134-34938. [DOI] [PubMed] [Google Scholar]
  24. HELLMAN L., ZUMOFF B., KESSLER G., KARA E., RUBIN I. L., ROSENFELD R. S. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE. J Atheroscler Res. 1963 Sep-Dec;3:454–466. doi: 10.1016/s0368-1319(63)80025-3. [DOI] [PubMed] [Google Scholar]
  25. Hall C. L., Ball E. G. Factors affecting lipolysis rates in rat adipose tissue. Biochim Biophys Acta. 1970 Jul 14;210(2):209–220. doi: 10.1016/0005-2760(70)90165-7. [DOI] [PubMed] [Google Scholar]
  26. Havel R. J., Kane J. P., Balasse E. O., Segel N., Basso L. V. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest. 1970 Nov;49(11):2017–2035. doi: 10.1172/JCI106422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Havel R. J., Kane J. P. Drugs and lipid metabolism. Annu Rev Pharmacol. 1973;13:287–308. doi: 10.1146/annurev.pa.13.040173.001443. [DOI] [PubMed] [Google Scholar]
  28. Heersche J. N., Fedak S. A., Aurbach G. D. The mode of action of dibutyryl adenosine 3',5'-monophosphate on bone tissue in vitro. J Biol Chem. 1971 Nov 25;246(22):6770–6775. [PubMed] [Google Scholar]
  29. Heimberg M., Weinstein I., Kohout M. The effects of glucagon, dibutyryl cyclic adenosine 3',5'-monophosphate, and concentration of free fatty acid on hepatic lipid metabolism. J Biol Chem. 1969 Oct 10;244(19):5131–5139. [PubMed] [Google Scholar]
  30. Horlick L., Kudchodkar B. J., Sodhi H. S. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man. Circulation. 1971 Feb;43(2):299–309. doi: 10.1161/01.cir.43.2.299. [DOI] [PubMed] [Google Scholar]
  31. Huttunen J. K., Steinberg D. Activation and phosphorylation of purified adipose tissue hormone-sensitive lipase by cyclic AMP-dependent protein kinase. Biochim Biophys Acta. 1971 Sep 1;239(3):411–427. doi: 10.1016/0005-2760(71)90034-8. [DOI] [PubMed] [Google Scholar]
  32. Jarett L., Steiner A. L., Smith R. M., Kipnis D. M. The involvement of cyclic AMP in the hormonal regulation of protein synthesis in rat adipocytes. Endocrinology. 1972 May;90(5):1277–1284. doi: 10.1210/endo-90-5-1277. [DOI] [PubMed] [Google Scholar]
  33. Kuo J. F., De Renzo E. C. A comparison of the effects of lipolytic and antilipolytic agents on adenosine 3',5'-monophosphate levels in adipose cells as determined by prior labeling with adenine-8-14C. J Biol Chem. 1969 May 10;244(9):2252–2260. [PubMed] [Google Scholar]
  34. Lamb R. G., Fallon H. J. Inhibition of monoacylglycerophosphate formation by chlorophenoxyisobutyrate and -benzalbutyrate. J Biol Chem. 1972 Feb 25;247(4):1281–1287. [PubMed] [Google Scholar]
  35. Loten E. G., Sneyd J. G. An effect of insulin on adipose-tissue adenosine 3':5'-cyclic monophosphate phosphodiesterase. Biochem J. 1970 Nov;120(1):187–193. doi: 10.1042/bj1200187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Manganiello V. C., Murad F., Vaughan M. Effects of lipolytic and antilipolytic agents on cyclic 3',5'-adenosine monophosphate in fat cells. J Biol Chem. 1971 Apr 10;246(7):2195–2202. [PubMed] [Google Scholar]
  37. Mishkel M. A., Webb W. F. The mechanisms underlying the hypolipidaemic effects of atromid S, nicotinic acid and benzalecene. I. The metabolism of free fatty acid-albumin complex by the isolated perfused liver. Biochem Pharmacol. 1967 May;16(5):897–905. doi: 10.1016/0006-2952(67)90062-7. [DOI] [PubMed] [Google Scholar]
  38. Nestel P. J., Austin W. The effect of ethyl chlorophenoxyisobutyrate (CPIB) on the uptake of triglyceride fatty acids, activity of lipoprotein lipase and lipogenesis from glucose in fat tissue of rats. J Atheroscler Res. 1968 Sep-Oct;8(5):827–833. doi: 10.1016/s0368-1319(68)80045-6. [DOI] [PubMed] [Google Scholar]
  39. Nikkilä E. A., Kekki M. Plasma endogenous triglyceride transport in hypertriglyceridaemia and effect of a hypolipidaemic drug (SU-13437). Eur J Clin Invest. 1972 Jun;2(4):231–238. doi: 10.1111/j.1365-2362.1972.tb00649.x. [DOI] [PubMed] [Google Scholar]
  40. OLIVER M. F. FURTHER OBSERVATIONS ON THE EFFECTS OF ATROMID AND OF ETHYL CHLOROPHENOXYISOBUTYRATE ON SERUM LIPID LEVELS. J Atheroscler Res. 1963 Sep-Dec;3:427–444. doi: 10.1016/s0368-1319(63)80023-x. [DOI] [PubMed] [Google Scholar]
  41. OLIVER M. F. Reduction of serum-lipid and uric-acid levels by an orally active androsterone. Lancet. 1962 Jun 23;1(7243):1321–1323. doi: 10.1016/s0140-6736(62)92422-4. [DOI] [PubMed] [Google Scholar]
  42. Patten R. L. The reciprocal regulation of lipoprotein lipase activity and hormone-sensitive lipase activity in rat adipocytes. J Biol Chem. 1970 Nov 10;245(21):5577–5584. [PubMed] [Google Scholar]
  43. RODBELL M. METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem. 1964 Feb;239:375–380. [PubMed] [Google Scholar]
  44. Rifkind B. M. Effect of CPIB ester on plasma free fatty acid levels in man. Metabolism. 1966 Aug;15(8):673–675. doi: 10.1016/s0026-0495(66)80001-x. [DOI] [PubMed] [Google Scholar]
  45. SHAPIRO B., CHOWERS I., ROSE G. Fatty acid uptake esterification in adipose tissue. Biochim Biophys Acta. 1957 Jan;23(1):115–120. doi: 10.1016/0006-3002(57)90292-5. [DOI] [PubMed] [Google Scholar]
  46. Schlierf G., Dorow E. Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis. J Clin Invest. 1973 Mar;52(3):732–740. doi: 10.1172/JCI107235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Schwabe U., Ebert R. Different effects of lipolytic hormones and phosphodiesterase inhibitors on cyclic 3',5'-AMP levels in isolated fat cells. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(3):287–298. doi: 10.1007/BF00501938. [DOI] [PubMed] [Google Scholar]
  48. Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev. 1972 Dec;24(4):583–655. [PubMed] [Google Scholar]
  49. Sodhi H. S., Kudchodkar B. J., Horlick L. Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man. Metabolism. 1971 Mar;20(3):309–318. doi: 10.1016/0026-0495(71)90115-6. [DOI] [PubMed] [Google Scholar]
  50. Svoboda D. J., Azarnoff D. L. Effects of selected hypolipidemic drugs on cell ultrastructure. Fed Proc. 1971 May-Jun;30(3):841–847. [PubMed] [Google Scholar]
  51. THORP J. M., WARING W. S. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate. Nature. 1962 Jun 9;194:948–949. doi: 10.1038/194948a0. [DOI] [PubMed] [Google Scholar]
  52. Tolman E. L., Tepperman H. M., Tepperman J. Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity. Am J Physiol. 1970 May;218(5):1313–1318. doi: 10.1152/ajplegacy.1970.218.5.1313. [DOI] [PubMed] [Google Scholar]
  53. Van Harken D. R., Dixon C. W., Heimberg M. Hepatic lipid metabolism in experimental diabetes. V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis. J Biol Chem. 1969 May 10;244(9):2278–2285. [PubMed] [Google Scholar]
  54. Westerfeld W. W., Elwood J. C., Richert D. A. Effect of clofibrate on the handling of dietary and liver fat. Biochem Pharmacol. 1972 Apr 15;21(8):1117–1125. doi: 10.1016/0006-2952(72)90105-0. [DOI] [PubMed] [Google Scholar]
  55. Wilcox H. G., Woodside W. F., Breen K. J., Knapp H. R., Jr, Heimberg M. The effect of sex on certain properties of the very low density lipoprotein secreted by the liver. Biochem Biophys Res Commun. 1974 Jun 18;58(4):919–926. doi: 10.1016/s0006-291x(74)80231-7. [DOI] [PubMed] [Google Scholar]
  56. Wilson D. E., Lees R. S. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J Clin Invest. 1972 May;51(5):1051–1057. doi: 10.1172/JCI106896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Windmueller H. G., Lindgren F. T., Lossow W. J., Levy R. I. On the nature of circulating lipoproteins of intestinal origin in the rat. Biochim Biophys Acta. 1970 May 5;202(3):507–516. doi: 10.1016/0005-2760(70)90121-9. [DOI] [PubMed] [Google Scholar]
  58. Wolfe B. M., Kane J. P., Havel R. J., Brewster H. P. Mechanism of the hypolipemic effect of clofibrate in postabsorptive man. J Clin Invest. 1973 Sep;52(9):2146–2159. doi: 10.1172/JCI107399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zinman B., Hollenberg C. H. Effect of insulin and lipolytic agents on rat adipocyte low Km cyclic adenosine 3':5'-monophosphate phosphodiesterase. J Biol Chem. 1974 Apr 10;249(7):2182–2187. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES